Soligenix
Developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and vaccines for certain bioterrorism agents. Learn more
Launch date
Employees
Market cap
AUD12.1m
Enterprise valuation
AUD2m (Public information from Sep 2024)
Share price
$3.83 SNGX
Princeton New Jersey (HQ)
Authorizing premium user...